AG-120 (ivosidenib)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AG-120 (ivosidenib), covering 2016-11-29 to 2025-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation [Phase 1]